Ionis Pharmaceuticals, Inc.
Compounds and methods for the modulation of proteins
Last updated:
Abstract:
In certain embodiments, the present disclosure provides compounds and methods of increasing the amount or activity of a target protein in a cell. In certain embodiments, the compounds comprise a translation suppression element inhibitor. In certain embodiments, the translation suppression element inhibitor is a uORF inhibitor. In certain embodiments, the uORF inhibitor is an antisense compound.
Status:
Grant
Type:
Utility
Filling date:
16 Nov 2015
Issue date:
3 Nov 2020